Azelnidipine may be a valuable drug for chemoprevention of ESCC with high MEK1/2 levels

Bibliographic Details
Main Author:	Haili Qian
Format:	Article
Language:	English
Published:	Elsevier 2022-12-01
Series:	Molecular Therapy: Oncolytics
Subjects:	azelnidipine ESCC MEK1/2 recurrence drug library
Online Access:	http://www.sciencedirect.com/science/article/pii/S2372770522001309

Internet